Cartalax 20mg

COA by Freedom Diagnostics
Lot PH-cx20-0202
COA 2605150494
Reported 05/18/2026
Verified

Average Purity

99.46%

Test Method

HPLC-MS

Identity

Pass

Endotoxin

Pass

Cartalax 20mg

◆ Product

Cartalax 20mg

View full product details and compound information.

View Product Details →

◆ 01

Sample Identification

Lab Freedom Diagnostics
Document Type Certificate of Analysis
COA Number 2605150494
Accession Number 2605150494
Search Code Prot2605150494
Client Protide Health
Product Cartalax 20mg
Lot PH-cx20-0202
Received Date 05/15/2026
Reported Date 05/18/2026

◆ 02

Purity & Quality Analysis

◆ Purity (HPLC)

  • Average Purity 99.46% ✓
  • Purity Vial 1 99.412% ✓
  • Purity Vial 2 99.513% ✓

◆ Net Peptide Content

  • Net Peptide Average 21.43 mg ✓
  • Net Peptide Vial 1 20.72 mg ✓
  • Net Peptide Vial 2 22.14 mg ✓

◆ Identity & Appearance

  • Identity Pass ✓
  • Appearance White Lyophilized Powder ✓

◆ Endotoxin (LAL)

  • Replicate 1 Pass ✓
  • Replicate 2 Pass ✓

◆ 03

Testing Methods & COA

◆ Certificate of Analysis

Source COA scan, Cartalax 20mg lot PH-cx20-0202
↓ Download PDF View in New Tab →

◆ Mass Identification

Cartalax

◆ Analysis Method

HPLC with UV detection coupled with mass spectrometry (LC-MS)

◆ Average Purity Result

99.46%

◆ Third-Party Verification

Third-party testing completed at Freedom Diagnostics, on 05/18/2026 by Alex Johnson.

  • COA Number 2605150494
  • Reported 05/18/2026
  • Lab Freedom Diagnostics

◆ 04

Test History for Cartalax 20mg

independent lab tests on file for this product.

COA 2605150494 · Lot PH-cx20-0202

This Certificate of Analysis is issued for laboratory research purposes only. Results are specific to the lot number indicated. This document does not authorize use in humans, animals, or any application outside of in-vitro research. Protide Health assumes no liability beyond documented analytical findings. For Research Use Only. Not for human use.